Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives


 4th November 2014 SMi Group

Agenda Released for the 14th Annual Advances and Progress in Drug Design Conference

Advances and Progress in Drug Design, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK

SMi Group are thrilled to announce that registration is now live to attend the 14th annual conference, Advances and Progress in Drug Design, taking place on 16th & 17th February 2015 in Central London.

The conference will ask questions such as: What are the key challenges in biotherapeutics discovery? How have computational and predictive tools matured for the application of drug discovery? Are there novel ways to inhibit kinase targets? How can we successfully apply ligand-based and structure based computational approaches for the rational design of novel GPCR antagonists? What are the best approaches in building a robust technology pipeline for robust fragment based drug discovery?

The agenda for 2015 will feature case study driven presentations from an array of market leaders such as the University of Cambridge, Janssen, MedImmune, Sanofi and Novartis, discussing computational approaches, structure based drug design, pharmacokinetics, polypharmacology, drug metabolism and fragment based drug design.

KEY SPEAKERS INCLUDE: Andreas Bender, Lecturer for Molecular, Informatics, University of Cambridge - CONFERENCE CHAIR Dr Hugo Gutierrez de Teran, Senior Researcher, Division of Computational and Systems Biology, Uppsala University - CONFERENCE CHAIR Gary Tresadern, Principal Scientist, Computational Chemistry, Lead Discovery, Janssen Research and Development Henrik Moebitz, Investigator, Novartis Sudharsan Sridharan, Scientist, MedImmune Ltd Gianni Chessari, Director, Computational Chemistry, Astex Pharmaceuticals Oliver Plettenburg, Head of Biosensors & Chemical Probes, Sanofi Michael Overduin, Professor of Structural Biology, University of Birmingham Dr Zara Sands, Principal Scientist, Medicinal Chemistry, UCB BioPharma Richard Lewis, Executive Director, Computer-Aided Drug Design, Novartis

Click here to see the full speaker line-up.

For those who are interested in attending, there is currently a 300 discount available online which expires on 31st October.

Further information can be found at

Advances and Progress in Drug Design 16-17 FEB 2015 Marriott Regents Park Hotel, London UK


Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |